RAINMED-B (02297) announced its results for the six months ended June 30, 2025. The group recorded revenue of HK$10.4 million during the period, representing a decrease of 61.3% year-over-year. The loss attributable to shareholders of the company was HK$32.2 million, narrowed by 22.6% year-over-year. Basic loss per share was HK$0.02.